PUBMED FOR HANDHELDS

Journal Abstract Search


225 related items for PubMed ID: 3393618

  • 1. Chronic caffeine consumption and the dexamethasone suppression test in depression.
    Lee MA, Flegel P, Cameron OG, Greden JF.
    Psychiatry Res; 1988 Apr; 24(1):61-5. PubMed ID: 3393618
    [Abstract] [Full Text] [Related]

  • 2. The lower limits of dexamethasone window in Chinese depressives.
    Shiah IS, Ko HC, Lu RB.
    Biol Psychiatry; 1998 Oct 01; 44(7):648-55. PubMed ID: 9787892
    [Abstract] [Full Text] [Related]

  • 3. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F, Gerken A, Steiger A, Fass V.
    Acta Psychiatr Scand; 1984 May 01; 69(5):383-90. PubMed ID: 6730994
    [Abstract] [Full Text] [Related]

  • 4. Depression, negative and positive symptoms, and the DST in schizophrenia.
    Minas IH, Jackson HJ, Joshua SD, Burgess PM.
    Schizophr Res; 1990 May 01; 3(5-6):321-7. PubMed ID: 2282337
    [Abstract] [Full Text] [Related]

  • 5. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M, De Ruyter M, Suy E.
    Psychoneuroendocrinology; 1989 May 01; 14(3):231-9. PubMed ID: 2756075
    [Abstract] [Full Text] [Related]

  • 6. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR, Weissenburger JE, Crowley GT, Khatami M, Vasavada N.
    J Clin Psychiatry; 1996 Oct 01; 57(10):470-84. PubMed ID: 8909334
    [Abstract] [Full Text] [Related]

  • 7. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
    Arch Gen Psychiatry; 1984 Mar 01; 41(3):257-67. PubMed ID: 6367690
    [Abstract] [Full Text] [Related]

  • 8. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I, Tuckwell VM, Maguire KP, Tiller JW, Harrison LC, Davies BM.
    Psychoneuroendocrinology; 1991 Mar 01; 16(5):375-82. PubMed ID: 1805291
    [Abstract] [Full Text] [Related]

  • 9. A longitudinal evaluation of dexamethasone and cortisol plasma concentrations in the dexamethasone suppression test before and during treatment with antidepressant drugs.
    Guthrie SK, Vartanian L, Grunhaus L, Hariharan M, Pande A, Haskett RF.
    Acta Psychiatr Scand; 1990 Dec 01; 82(6):427-32. PubMed ID: 2291411
    [Abstract] [Full Text] [Related]

  • 10. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW, Halbreich U, Yeh CM, Asnis G, Goldstein S.
    Biol Psychiatry; 1988 Sep 01; 24(5):569-77. PubMed ID: 3167145
    [Abstract] [Full Text] [Related]

  • 11. An augmented escape of androstenedione from suppression by dexamethasone in melancholia: relationships to intact ACTH and cortisol nonsuppression.
    Maes M, Van Gastel A, Blockx P, Martin M, Cosyns P, Scharpé S, Desnyder R.
    J Affect Disord; 1995 Aug 18; 34(4):291-300. PubMed ID: 8550955
    [Abstract] [Full Text] [Related]

  • 12. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF, Hunt G, Kerr K, Caterson I.
    Psychiatry Res; 1984 Dec 18; 13(4):305-13. PubMed ID: 6596587
    [Abstract] [Full Text] [Related]

  • 13. Severity of depression and hypothalamic-pituitary-adrenal axis dysregulation: identification of contributing factors.
    Meador-Woodruff JH, Greden JF, Grunhaus L, Haskett RF.
    Acta Psychiatr Scand; 1990 Apr 18; 81(4):364-71. PubMed ID: 2343764
    [Abstract] [Full Text] [Related]

  • 14. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
    Arch Gen Psychiatry; 1987 Sep 18; 44(9):790-5. PubMed ID: 3632252
    [Abstract] [Full Text] [Related]

  • 15. Dexamethasone suppression test in depression with reversible dementia.
    Alexopoulos GS, Young RC, Haycox JA, Shamoian CA, Blass JP.
    Psychiatry Res; 1985 Dec 18; 16(4):277-85. PubMed ID: 4089057
    [Abstract] [Full Text] [Related]

  • 16. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S, Zander J, Garvey M.
    J Clin Psychiatry; 1984 Sep 18; 45(9):390-2. PubMed ID: 6469924
    [Abstract] [Full Text] [Related]

  • 17. Effects of antidepressant withdrawal on the dexamethasone suppression test.
    Dilsaver SC, Greden JF.
    Psychiatry Res; 1985 Feb 18; 14(2):11-22. PubMed ID: 3857651
    [Abstract] [Full Text] [Related]

  • 18. Dexamethasone nonsuppression in chronic schizophrenia.
    Whiteford HA, Riney SJ, Savala RA, Csernansky JG.
    Acta Psychiatr Scand; 1988 Jan 18; 77(1):58-62. PubMed ID: 3273153
    [Abstract] [Full Text] [Related]

  • 19. The role of stress in interpreting the dexamethasone suppression test.
    Blouin J, Spindler E, Perez E, Blouin A, Hotz S, Hakkaku J.
    Can J Psychiatry; 1992 Dec 18; 37(10):724-7. PubMed ID: 1473078
    [Abstract] [Full Text] [Related]

  • 20. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D, Addington J.
    Can J Psychiatry; 1990 Jun 18; 35(5):430-3. PubMed ID: 2372754
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.